Rare
lephants
Screener
Toggle theme
I
INTERPACE BIOSCIENCES, INC.
IDXGD
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2011
FY2010
Total Cash from Operations:
$16.4M
Line Item
Value
% of Total
Capital Expenditures
$1.3M
8.2%
Business Acquisitions
$15.0M
91.6%
Stock Repurchases
$38.8K
0.2%
Net Cash Flow
$0
0.0%
Download CSV